HOB Financial Statements From 2010 to 2026

Stocks . China . 
Stock . HOB Biotech Group
688656 Stock   154.25  2.40  1.53%   
HOB Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing HOB Biotech's valuation are provided below:
Gross Profit
232.5 M
Profit Margin
0.094
Market Capitalization
9.8 B
Enterprise Value Revenue
25.6544
Revenue
387.5 M
We have found seventy-four available fundamental measures for HOB Biotech, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to confirm all of HOB Biotech latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself for few more years.

HOB Biotech Total Revenue

290.3 Million

Check HOB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HOB Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 47.3 M, Interest Expense of 2.2 M or Selling General Administrative of 78.8 M, as well as many indicators such as . HOB financial statements analysis is a perfect complement when working with HOB Biotech Valuation or Volatility modules.
  
This module can also supplement various HOB Biotech Technical models . Check out the analysis of HOB Biotech Correlation against competitors.

HOB Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets594.5 M1.2 B435 M
Slightly volatile
Short and Long Term Debt Total138.4 M131.8 M55.6 M
Slightly volatile
Other Current Liabilities48.5 M58.8 M35.6 M
Slightly volatile
Total Current Liabilities253.5 M241.4 M104.7 M
Slightly volatile
Total Stockholder Equity980.7 M934 M356 M
Slightly volatile
Property Plant And Equipment Net852.1 M811.6 M257.1 M
Slightly volatile
Current Deferred Revenue29.7 M15.3 M20.5 M
Pretty Stable
Retained Earnings210.1 M200.1 M74.1 M
Slightly volatile
Accounts Payable53.8 M51.3 M17.6 M
Slightly volatile
Cash138.3 M139.9 M87.5 M
Slightly volatile
Non Current Assets Total894.4 M851.8 M284.2 M
Slightly volatile
Non Currrent Assets Other25.1 M23.9 M8.3 M
Slightly volatile
Cash And Short Term Investments155.5 M139.9 M96.8 M
Slightly volatile
Net Receivables31.9 M58.6 M23.2 M
Slightly volatile
Common Stock Shares Outstanding63.1 M73 M54.4 M
Slightly volatile
Liabilities And Stockholders Equity594.5 M1.2 B435 M
Slightly volatile
Non Current Liabilities Total9.9 M9.7 M12.3 M
Slightly volatile
Inventory75.5 M127.9 M58.9 M
Slightly volatile
Other Current Assets10.2 M9.5 M7.6 M
Slightly volatile
Other Stockholder Equity694.4 M661.3 M241.6 M
Slightly volatile
Total Liabilities130.4 M253.8 M109.3 M
Slightly volatile
Total Current Assets270.1 M335.9 M184.3 M
Slightly volatile
Accumulated Other Comprehensive Income41.7 M38.2 M24.6 M
Slightly volatile
Short Term Debt126.9 M120.8 M46.4 M
Slightly volatile
Intangible Assets8.7 M11.6 M5.6 M
Slightly volatile
Common Stock55.2 M72.5 M38.6 M
Slightly volatile
Long Term Debt13.6 M9.2 M7.6 M
Slightly volatile
Net Invested Capital708.9 M1.1 B437.5 M
Slightly volatile
Short and Long Term Debt126.9 M120.8 M56.1 M
Slightly volatile
Capital Stock63.6 M72.5 M53.4 M
Slightly volatile
Non Current Liabilities Other1.8 M2 M2.2 M
Slightly volatile
Net Working Capital89.8 M94.5 M108.5 M
Slightly volatile
Capital Lease Obligations1.3 M1.4 M6.5 M
Slightly volatile
Property Plant And Equipment Gross579.9 M986.3 M351.4 M
Slightly volatile
Short Term Investments163.3 M155.5 M46.2 M
Slightly volatile

HOB Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization47.3 M45 M15.8 M
Slightly volatile
Interest Expense2.2 M3.5 M1.9 M
Slightly volatile
Selling General Administrative78.8 M75.1 M28.5 M
Slightly volatile
Selling And Marketing Expenses66.4 M108.1 M52.9 M
Slightly volatile
Total Revenue290.3 M462.7 M223.4 M
Slightly volatile
Gross Profit191 M295.8 M146.4 M
Slightly volatile
Other Operating Expenses234.8 M415.1 M189.5 M
Slightly volatile
Operating Income55.5 M47.6 M33.9 M
Slightly volatile
EBIT53.6 M50.8 M33.6 M
Slightly volatile
Research Development34.3 M53.2 M29.9 M
Slightly volatile
EBITDA73.9 M95.8 M47.8 M
Slightly volatile
Cost Of Revenue99.3 M166.9 M77 M
Slightly volatile
Total Operating Expenses135.5 M248.2 M112.5 M
Slightly volatile
Income Before Tax55.9 M47.2 M34.5 M
Slightly volatile
Net Income48.7 M42.3 M30.3 M
Slightly volatile
Tax Provision6.6 M3.8 M8.7 M
Slightly volatile
Interest Income980.8 K803.8 K713.6 K
Slightly volatile
Net Income From Continuing Ops44.3 M33.1 M57.9 M
Slightly volatile
Reconciled Depreciation31.3 M51.9 M22 M
Slightly volatile

HOB Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.7 M1.1 M2.1 M
Slightly volatile
Begin Period Cash Flow125.2 M188 M83.7 M
Slightly volatile
Depreciation54.5 M51.9 M19.6 M
Slightly volatile
Dividends Paid24.8 M32.4 M15.8 M
Slightly volatile
Capital Expenditures107.3 M178.7 M74.5 M
Slightly volatile
Total Cash From Operating Activities69.5 M116.4 M46.7 M
Slightly volatile
Net Income48.7 M42.3 M30.3 M
Slightly volatile
End Period Cash Flow138.3 M139.9 M87.5 M
Slightly volatile
Other Cashflows From Investing Activities894.8 K493.5 K1.3 M
Slightly volatile

HOB Fundamental Market Drivers

About HOB Biotech Financial Statements

HOB Biotech stakeholders use historical fundamental indicators, such as HOB Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although HOB Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in HOB Biotech's assets and liabilities are reflected in the revenues and expenses on HOB Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HOB Biotech Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue15.3 M29.7 M
Total Revenue462.7 M290.3 M
Cost Of Revenue166.9 M99.3 M

Currently Active Assets on Macroaxis

GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
GOOGAlphabet Inc Class C
GMGeneral Motors

Other Information on Investing in HOB Stock

HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY